News + Font Resize -

CPhI India 2011 to be held in Mumbai from Nov 30 to Dec 2
Our Bureau, Mumbai | Friday, November 18, 2011, 15:00 Hrs  [IST]

CPhI India, the largest and most comprehensive pharmaceutical event in South Asia will be held in Mumbai from November 30 to December 2, 2011.

The event will be held at the Bombay Exhibition Centre (BEC), Goregaon (East). Focused on pharmaceutical ingredients, CPhI India will be joined by co-located events: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market.

The CPhI India Conference Series, taking place alongside the CPhI India exhibition  will be  providing  the details on the  key opportunities and challenges currently facing the Indian pharma industry.

This unique three-day event comprises six interactive half-day seminars. These six  half-day seminars consist of three expert presentations and a 40-minute interactive panel debate including a networking lunch.

One can select from any of the following half-day seminars:

Competitive API Strategies :  November 30, 8:30-12:00
Understand ever-changing pricing trends and demand-supply dynamics of the Indian API industry and learn new technological advancements and revenue streams to effectively compete on the global stage

Maximising Export Potential: November 30, 12:15-16:00
Gain in-depth insights into the market dynamics, pricing strategies and regulatory requirements in key export markets to ensure rapid commercialisation of your product

Developing Difficult Generics:  December 1, 8:30-12:00
Learn innovative solutions and practical insights to overcome challenges around developing difficult generics at various product development stages

Consumer Healthcare and OTC Drugs: December 1, 12:15-16:00
Benefit from in-depth guidance on the market dynamics, regulatory requirements and effective commercialisation of your OTC products

Global Biosimilar Regulations: December 2, 8:30-12:00
Determine the latest global regulatory developments in the  biosimilars space and ensure swift regulatory approval and compliance with the US, EU and other emerging markets

Global Clinical Trials: December 2, 12:15-16:00
Identify and overcome the complexities involved in meeting product registration and GCP requirements in the regulated and semi-regulated markets.

By attending  the CPhI India Conference Series, one can  gain valuable insights into the latest trends, current competitive scenario, new market opportunities, recent innovations and technological advancements and evolving regulations in the Indian pharmaceuticals industry.

For more information, contact: Asan Bano Tel: +91 (022) 4046 1466
Email: conferences-india@ubm.com

Post Your Comment

 

Enquiry Form